GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » YoY EBITDA Growth

Touyun Biotech Group (HKSE:01332) YoY EBITDA Growth : -65.00% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Touyun Biotech Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -65.00%.

Touyun Biotech Group's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.07.


Touyun Biotech Group YoY EBITDA Growth Historical Data

The historical data trend for Touyun Biotech Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group YoY EBITDA Growth Chart

Touyun Biotech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.32 25.00 28.57 -70.00 -58.82

Touyun Biotech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.44 - -166.67 -26.09 -65.00

Touyun Biotech Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Touyun Biotech Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.081--0.051)/ | -0.051 |
=-58.82 %

Touyun Biotech Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.066--0.04)/ | -0.04 |
=-65.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Touyun Biotech Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Touyun Biotech Group (HKSE:01332) Business Description

Traded in Other Exchanges
N/A
Address
6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.
Executives
Wang Liang 2101 Beneficial owner
Tian Yuze 2101 Beneficial owner
Tian Yuze 2101 Beneficial owner
Qiao Yanfeng 2201 Interest of corporation controlled by you
Qin Fen 2101 Beneficial owner

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines